植入式心律转复除颤器患者全因死亡列线图的开发与验证
本研究基于中国2010至2014年多中心ICD注册数据,以617例患者为开发队列、196例为验证队列,构建并验证预测ICD患者全因死亡的列线图。模型纳入ICD监测的体力活动、糖尿病和左心室舒张末期内径三个因素,开发队列C指数为0.80,验证队列C指数为0.74,校准曲线显示预测与实际情况一致性良好。
要点
- 列线图纳入体力活动、糖尿病、左心室舒张末期内径三个预测因素。
- 开发队列C指数0.80,验证队列C指数0.74,校准一致性良好。
- 该模型在一级与二级预防亚组及心源性死亡、心脏性猝死预测中保持稳定。
核心结论
- 该列线图整合ICD监测的体力活动与临床数据,可为ICD患者提供个体化死亡风险评估。
研究设计与样本
- 回顾性分析中国2010至2014年多中心ICD注册研究数据。
- 开发队列共617例ICD患者,验证队列共196例ICD患者。
- 采用单因素和多因素Cox回归筛选预测因素并构建列线图,以C指数和校准曲线评价模型性能。
主要发现
- 在开发队列中,体力活动、糖尿病和左心室舒张末期内径被选为独立预后因素。
- 列线图在开发队列的C指数为0.80(95% CI 0.75至0.84)。
- 列线图在验证队列的C指数为0.74(95% CI 0.64至0.84),校准曲线仍保持良好一致性。
- 列线图在一级和二级预防亚组中保持稳定且良好的区分能力,对特定心源性死亡和心脏性猝死的预测亦保持稳定。
关键数值与推荐
- 开发队列C指数为0.80(95% CI 0.75至0.84)。
- 验证队列C指数为0.74(95% CI 0.64至0.84)。
- 列线图由体力活动、糖尿病和左心室舒张末期内径三个因素构建。
临床怎么用
- 该列线图可用于对ICD患者进行个体化全因死亡风险评估。
- 模型在一级与二级预防人群中均可考虑用于死亡风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background For patients with a high risk of sudden cardiac death, despite the benefits of an implantable cardioverter defibrillator (ICD), some patients are still at high risk of death. Aim The purpose of this study was to develop and validate a nomogram predicting all-cause mortality for patients with an ICD. Methods We retrospectively analysed the data of multicentre ICD registration study from 2010 to 2014 in China. A total of 617 ICD patients formed a development cohort. The physical activity monitored by ICD and clinical data was collected. Univariate and multivariate Cox regression analyses were used to screen mortality predictors and construct the nomogram. The performance of the nomogram was evaluated by the consistency index (C-index) and the calibration curve. Additionally, extensive subgroup and sensitivity analyses were conducted to evaluate the model’s robustness. A total of 196 ICD patients formed a validation cohort. Results In the development cohort, physical activity, diabetes and left ventricular end-diastolic diameter were selected as independent prognostic factors. The nomogram was constructed by these three factors. The C-index of the nomogram was 0.80 (95% CI 0.75 to 0.84). The calibration curve showed that the predicted survival probability of the nomogram was in good agreement with the actual survival probability. In the validation cohort, the C-index of the nomogram was 0.74 (95% CI 0.64 to 0.84), and the calibration curve still maintained good consistency. Crucially, the nomogram maintained stable and excellent discriminative capacity across primary and secondary prevention subgroups, as well as for predicting specific cardiac and sudden cardiac death. Conclusions Our study develops and validates a nomogram predicting all-cause mortality for patients with an ICD by integrating the physical activity monitored by ICD and clinical data. The nomogram performs well and can provide personalised death risk assessment for ICD patients. Trial registration number ChiCTR-ONRC-13003695.
引用
- Open Heart:Development and validation of a nomogram predicting all-cause mortality for patients with an implantable cardioverter defibrillator
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。